
According to data from Benzinga Pro, during Q2, MEI Pharma's (NASDAQ:MEIP) reported sales totaled $18.22 million. Despite a 51.46% increase in earnings, the company posted a loss of $5.77 million. In Q1, MEI Pharma brought in $13.39 million in sales but lost $11.88 million in earnings.